Artal Group’s Fate Therapeutics FATE Stock Holding History

Artal Group’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,032,500	Closed	-$3.39M	–	35
2024 Q2	$3.39M	Buy	1,032,500 +672,189	+187%	+$2.94M	0.09%	65
2024 Q1	$2.64M	Buy	+360,311	New	+$2.23M	0.07%	79
2023 Q2	–	Sell	-2,600,000	Closed	-$14.8M	–	125
2023 Q1	$14.8M	Hold	2,600,000	–	–	0.88%	29
2022 Q4	$26.2M	Hold	2,600,000	–	–	1.51%	22
2022 Q3	$58.3M	Hold	2,600,000	–	–	3.04%	10
2022 Q2	$64.4M	Buy	2,600,000 +600,000	+30%	+$16.6M	3.58%	9
2022 Q1	$77.5M	Buy	2,000,000 +200,000	+11%	+$7.74M	3.28%	8
2021 Q4	$105M	Buy	1,800,000 +350,000	+24%	+$19.8M	3.1%	9
2021 Q3	$85.9M	Buy	1,450,000 +100,000	+7%	+$7.84M	2.11%	13
2021 Q2	$117M	Buy	1,350,000 +50,000	+4%	+$4.03M	2.67%	11
2021 Q1	$107M	Sell	1,300,000 -100,000	-7%	-$9.58M	2.27%	12
2020 Q4	$127M	Sell	1,400,000 -100,000	-7%	-$6.21M	2.91%	6
2020 Q3	$60M	Sell	1,500,000 -300,000	-17%	-$10.5M	1.98%	16
2020 Q2	$61.8M	Sell	1,800,000 -300,000	-14%	-$8.94M	2.1%	13
2020 Q1	$46.6M	Buy	2,100,000 +100,000	+5%	+$2.53M	2.23%	13
2019 Q4	$39.1M	Hold	2,000,000	–	–	1.63%	13
2019 Q3	$31.1M	Buy	2,000,000 +500,000	+33%	+$9.58M	1.51%	16
2019 Q2	$30.4M	Sell	1,500,000 -300,000	-17%	-$5.41M	1.4%	20
2019 Q1	$31.6M	Sell	1,800,000 -350,000	-16%	-$5.52M	1.51%	20
2018 Q4	$27.6M	Sell	2,150,000 -40,000	-2%	-$558K	1.38%	23
2018 Q3	$35.7M	Buy	2,190,000 +490,000	+29%	+$5.79M	1.24%	19
2018 Q2	$19.3M	Buy	1,700,000 +850,000	+100%	+$9.36M	0.5%	25
2018 Q1	$8.3M	Buy	+850,000	New	+$8.14M	0.12%	54

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return